Inhibition of nitric oxide synthesis following severe hypoxia-ischemia restores autoregulation of cerebral blood flow in newborn lambs
Introduction
Following severe perinatal hypoxia-ischemia (birth asphyxia) the autoregulatory ability of the neonatal cerebral vascular bed is often impaired [1], [2]. There is an increasing body of evidence that excess production of nitric oxide is important in this respect because of its strong vasodilatory action [3], [4]. Earlier studies in newborn animals reported indeed an substantial increase of nitric oxide during, especially following reperfusion and reoxygenation after perinatal hypoxia and ischemia [5], [6], [7]. Since an appropriate cerebral perfusion is mandatory to prevent further brain damage in the early post-hypoxic-ischemic period, prompt recovery of the autoregulatory ability of the cerebral vascular bed is essential.
In the present study we investigated whether or not inhibition of nitric oxide synthesis upon reperfusion and reoxygenation after severe hypoxia-ischemia in newborn lambs restores cerebral blood flow autoregulation in the early post-ictal period. We hypothesized that NLA restores post-hypoxia-ischemia autoregulatory ability of the cerebral vascular bed. Inhibition of nitric oxide synthesis was performed with an analog of l-arginine (the precursor of nitric oxide), Nω-Nitro-l-Arginine (NLA), which is a non-selective nitric oxide synthase inhibitor. Since nitric oxide has also a physiological role [8], [9] and recent studies suggested that partial rather than total nitric oxide synthase inhibition shows a neuroprotective effect after hypoxia-ischemia [10], [11], we divided our treatment group into a low dose (10 mg NLA/kg: partial nitric oxide synthase inhibition) and a high dose (40 mg NLA/kg: total nitric oxide synthase inhibition [12]) subgroup.
Section snippets
Animal preparation
Surgical and experimental procedures used were reviewed and approved by the Animal Research Committee of the Leiden University Hospital and the scientific board of the Department of Pediatrics. Sixteen newborn lambs, weight ranging from 3.1 to 5.8 kg (median 4.4 kg) and ages ranging from 2 to 9 days (median: 6 days) were studied. General anesthesia was induced with a bolus of ketamine hydrochloride (3 mg/kg i.v.) and supplemented by xylazine (1 mg/kg/3 h i.m.) and local subeutaneous injection
Results
There were no differences between the 3 groups with respect to weight or postnatal age. The amount of bicarbonate infused to treat the severe metabolic acidosis in the immediate post-HI period was not different between groups. Table 1 summarizes the mean values (±1S.D.) of Qcar, MABP, arterial pH and base excess, blood gases and cerebral venous lactate concentration during the various time points. Qcar was higher in the PLAC-group as compared to the NLA-treated groups, although this was only
Discussion
Our study confirms earlier findings that severe hypoxic-ischemia in the newborn lamb impairs the autoregulatory abilty of the cerebral vascular bed after restoration of perfusion and oxygenation. It further shows that inhibition of nitric oxide production with NLA recovers this autoregulatory ability in the early post-hypoxic-ischemic period and extended the upper limit of cerebral autoregulation to higher MABPs (NLA-40 lambs). Even partial nitric oxide production blockade with low dose NLA (10
List of abbreviations
- HI
Hypoxia-ischemia
- MABP
Mean aortic blood pressure
- NLA
Nω-Nitro-l-Arginine
- PLAC
Placebo
- Qcar
Carotid artery blood flow
References (39)
- et al.
Impaired autoregulation of cerebral blood flow in the distressed newborn infant
J Pediatr
(1979) - et al.
Electron paramagnetic resonance study on nitric oxide production during brain focal ischemia and reperfusion in the rat
Brain Res
(1994) - et al.
Delivoria-Papadopoulos M. Cytosolic and membrane-bound cerebral nitric oxide synthase activity during hypoxia in cortical tissue of newborn piglets
Neurosci Lett
(1996) Nitric oxide: mediator, murderer, and medicine
Lancet
(1994)- et al.
Dual role of nitric oxide in focal cerebral ischemia
Neuropharmacol
(1994) - et al.
The role of nitric oxide in the regulation of cerebral blood flow
Brain Res
(1993) - et al.
Role of nitric oxide in regulation of cerebral microvascular tone and autoregulation of cerebral blood flow in cats
Brain Res
(1994) - et al.
Deregulation of cyclooxygenase and nitric oxide synthase gene expression in the inflammatory cascade triggered by experimental group B streptococcal meningitis in the newborn brain and cerebral microvessels
Semiti Perinatol
(1999) - et al.
Preservation of autoregulatory cerebral vasodilator responses to hypotension after inhibition of nitric oxide synthesis
Brain Res
(1995) - et al.
Impairment of cerebral blood flow autoregulation in the newborn lamb by hypoxia
Pediatr Res
(1986)
Control of cerebral and ocular blood flow autoregulation in neonates
Pediatr Clin North Am
Developmentally increased cerebrovascular NO in newborn pigs curtails cerebral blood flow autoregulation
Pediatr Res
Cerebral blood flow is reduced by N-omega-nitro-l-arginine methyl ester during delayed hypoperfusion in cats
Am J Physiol
Low dose l-NAME during transient focal cerebral ischemia in spontaneously hypertensive rats
Am J Physiol
Inhibition of nitric oxide synthase after cerebral hypoxia ischemia reduces brain swelling in neonatal rats: a dose response study
Pediatr Res
Nω-Nitro-l-arginine attenuates endotheliumdependent pulmonary vasodilation in lambs
Am J Physiol
Performance of a cuff-type blood flowmeter invivo
J Appl Physiol
In vivo calibration of a transittime ultrasound system for measuring ascending aorta volume flow
Pharmacologist
Relationship between brain blood flow and carotid arterial flow in the sheep fetus
Pediatr Res
Cited by (10)
Age-related changes and effects of mild hypothermia on carotid artery reactivity in newborn rats
2015, CNS and Neurological Disorders - Drug TargetsBrain apoptosis and carotid artery reactivity in fetal asphyctic preconditioning
2010, Frontiers in Bioscience - ScholarCerebral blood flow regulation by nitric oxide: Recent advances
2009, Pharmacological Reviews